The drug Klayra continues a series of combined oral contraceptives. The most important functions of the drug are the suppression of the ovulation process and the effect on the properties of cervical mucus. In addition to preventing pregnancy, the drug has a number of positive properties, which makes it predominant when a woman chooses contraception. Among the positive qualities, it is worth highlighting a decrease in the intensity and soreness in women that occurs during menstrual bleeding. As a result, patients are less likely to develop iron deficiency. In medical studies, there is evidence of a decrease in the likelihood of women developing ovarian and endometrial cancer.
Coated tablets are the only form of release of the drug “Klayra”. Instructions for use indicate that one blister of medication contains 28 tablets of various shapes and colors: 2 dark yellow, red and white, 5 pink and 17 pale yellow tablets. Each blister is pasted into a folding bed, which, in addition to the medicine, contains a self-adhesive calendar for taking the drug and instructions for it.
Means “Klaira” as estrogen contains estradiol valerate, which, unlike its predecessors, has a higher ability to metabolize and to a lesser extent affects the liver. Denoting the positive effects of the drug, we can say that it is the first contraceptive, which includes estrogen, which is almost identical to natural, which is a long-awaited discovery in the field of contraception.
The drug "Klayra": instructions for use. Contraindications
The only indication for the use of the drug is pregnancy prevention. There are a number of contraindications to the use of the drug "Klayra". Instructions for use warns that in the presence of one of the following conditions, tablets should not be taken:
- thrombosis (venous and arterial), myocardial infarction, thromboembolism (both at this time and in history);
- ischemia, angina pectoris (including medical history);
- the presence of many factors that are the precursors of thrombosis;
- diabetes;
- migraine with severe neurological abnormalities;
- pancreatitis;
- liver disease;
- malignant or benign tumors of the liver;
- detected tumors (malignant hormone-dependent);
- vaginal bleeding (of unknown origin);
- Suspicion of pregnancy and pregnancy ;
- sensitivity to the components of the drug.
The drug "Klayra": side effects
There are a number of specific instructions for the contraceptive Klaira. Instructions for use warns about the possibility of side effects of the drug if you ignore at least one of the following symptoms:
- t rhombosis . Women taking the drug have an increased risk of developing thrombosis, although it is not as high as in pregnant women. It is recommended to stop smoking during the period of taking the medicine, especially for women whose age has exceeded 35 years. The doctor may prohibit taking the drug if the patient has already been done or has to undergo a surgical operation, because the risk of developing thrombosis increases with an immovable lifestyle. The same advice will follow if a woman has high blood pressure.
- tumors. On the background of taking hormonal drugs in some cases, the development of not only benign tumors is observed. It is extremely rare, but patients with developing malignant tumors in the liver appeared, which carries a risk to life and the risk of internal bleeding.
- a decrease in the degree of effectiveness. In order to maintain a high level of effectiveness of the drug “Klayra”, the instructions for use recommend taking tablets strictly according to the scheme and avoid omissions. It is important to consider that diarrhea and vomiting are equivalent to the fact that the dose was not taken, this reduces the effectiveness of the entire treatment.
- angioedema. In women with With a diagnosis, taking the drug develops a risk of worsening symptoms of the disease.
Acceptance of hormonal contraceptives such as “Klayra” should be accompanied by regular testing, because there is information about the negative effect of the drug on some indicators of laboratory tests.